论文部分内容阅读
目的 评价Eales′病在玻璃体切割术前视网膜光凝的意义。方法 回顾解放军总医院从 1995年～ 2 0 0 4年住院的Eales′病人 ,130例 (14 1眼 ) ,均做过玻璃体切割术 ,年龄 18岁～ 4 5岁 ,平均 2 8 5岁 ,平均随访 4 8 8月。根据是否术前行过视网膜光凝将其分为激光治疗组 (32眼 )和无激光治疗组 (10 9眼 ) ,比较两组患者术中术后并发症、术后视力改善及视网膜复位情况。结果 激光治疗组术中并发症 2眼 (6 2 5 % ) ,术后并发症 5眼 (15 6 2 % ) ,无激光治疗组术中并发症 2 4眼(2 2 0 2 % ) ,术后并发症 37眼 (33 94 % )。 73眼视网膜脱离 ,手术复位成功 5 9眼 (80 82 % ) ,激光治疗组 2 1眼复位成功 2 0眼 (95 2 4 % ) ,无激光治疗组 5 2眼复位成功 39眼 (75 0 0 % )。激光治疗组术后视力明显提高 ,无激光治疗组视力有所改善。统计学处理均有显著性差异。结论 氩激光视网膜光凝是治疗Eales′病的一种有效方法 ,如能在玻璃体切割术前行光凝治疗 ,手术预后明显好于未行激光治疗的Eales′病患者。建议在Eales′病早期的患者尽可能使用氩激光视网膜光凝术。
Objective To evaluate the significance of Eales’s disease in retinal photocoagulation before vitrectomy. Methods The Eales’ patients and 130 eyes (141 eyes) hospitalized in PLA General Hospital from 1995 to 2004 were retrospectively reviewed. All patients underwent vitrectomy, ranging in age from 18 to 45 years (average, 285) Follow-up 48 August. According to whether preoperative retinal photocoagulation was divided into laser treatment group (32 eyes) and no laser treatment group (109 eyes), the postoperative complications, postoperative visual acuity and retinal reattachment were compared . Results There were 2 eyes (62.5%) in the laser treatment group, 5 eyes (15.62%) in the postoperative complications, 24 eyes (22.02%) in the non - laser treatment group, Postoperative complications occurred in 37 eyes (33 94%). In 73 eyes with retinal detachment, 59 eyes (80 82%) were successful in the surgical procedure, 20 eyes (95 2 4%) were successfully restored in the laser treatment group and 39 eyes (75 0 0) in the non-laser treatment group %). The postoperative visual acuity of the laser treatment group was significantly improved, and the visual acuity of the laser treatment group was improved. Statistical analysis showed significant differences. Conclusion Argon laser photocoagulation is an effective method to treat Eales ’disease. If laser photocoagulation is performed before vitrectomy, the prognosis of surgery is significantly better than that of Eales’ patients without laser treatment. It is recommended that argon laser retinal photocoagulation be used whenever possible in patients with early Eales disease.